Coronavirus disease 2019 (COVID-19) is a multi-system disease that causes multiple complications. It is linked to the development of new-onset diabetes or unmasking of underlying diabetes. Despite the uncertain exact mechanism, pancreatic angiotensin-converting enzyme 2 (ACE2) receptor, the main enzyme related to COVID-19 pathophysiology has been implied. COVID-19 vaccine was authorized to help control the rapid spread of COVID-19 disease. We report a case of new-onset diabetes type 2 presenting as hyperosmolar hyperglycemic state (HHS) in a patient after receiving COVID-19 vaccine with some literature review of the potential mechanisms by which COVID-19 may cause new-onset diabetes type 2.
covid-19, covid-19 vaccine, hyperosmolar hyperglycemic state, new-onset diabetes, type 2 diabetes
Abu-Rumaileh MA, Gharaibeh AM, Gharaibeh NE. COVID-19 Vaccine and Hyperosmolar Hyperglycemic State. Cureus. 2021; 13(3). doi: 10.7759/cureus.14125.